To quantify the effect of therapy on the fraction of cancer stem cells in vivo, we digested the xenograft tumors, generated single-cell suspensions, stained them for ALDH activity and CD44 expression, and sorted ALDHhighCD44high cells by flow cytometry. Here, CD44 is linked to cancer.